Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Antiviral drugs: Economic incentives and strategies for pandemic preparedness : report to congressional committees
Antiviral drugs: Economic incentives and strategies for pandemic preparedness : report to congressional committees
Why GAO did this study. Pandemics impose large human and economic costs on society. According to the World Health Organization, almost 7 million people died worldwide during the COVID-19 pandemic. The International Monetary Fund estimates that by 2024, COVID-19 will have reduced global economic output by $13.8 trillion relative to prepandemic forecasts. Scientists have predicted that another pandemic is highly likely. The CARES Act included a provision for GAO to report on the federal response to the COVID-19 pandemic. This report discusses incentives and strategies to enhance antiviral drug investment. GAO reviewed economic and scientific literature relevant to these areas. GAO also interviewed stakeholders and experts with perspectives on the science and economics of antiviral drug development, including those at HHS. In addition, GAO convened, with assistance from the National Academies of Sciences, Engineering, and Medicine, a 2-day meeting of 16 experts. GAO is identifying policy options in this report.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)